跳至主要内容
临床试验/CTRI/2009/091/000613
CTRI/2009/091/000613已完成2 期

Prospective, randomized, open-labeled, parallel group clinical study to evaluate safety and efficacy of R-HSC-001 in patients with Spinal Cord Injury

Reliance Life Sciences Pvt Ltd0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of ages more than 18 and less than 70 years (18 and 70 years inclusive)
  • 2. Patients with acute thoracic (T2 to T12) or cervical spinal cord injury (C1-T1) and Frankel score of at least B. Patients with complete or partial transaction/damage as shown by MRI.

排除标准

  • 1. Significant head trauma or any other injury which in the opinion of the investigator, is sufficient to interfere with the assessment of spinal cord function or otherwise compromise the validity of the patient?s data
  • 2.Hemodynamically unstable patients
  • 3.History of or concurrent autoimmune disease or an acute episode of Guillain-Barre syndrome
  • 4.AST/ALT of 2.5 X upper limit of normal and Serum Creatinine 2 X upper limit of normal
  • 5.Severe skin infection and osteomyelitis /or at the site of bone marrow aspiration potentially limiting the procedure
  • 6.Presence of a primary hematological disease or any coagulation abnormalities or concomitant treatment with coumarin anti-coagulant
  • 7.Women of child-bearing potential unwilling to use effective barrier method of contraception for the duration of the study
  • 16.Alcohol and/or drug abuse/dependency
  • 17.Pregnant or nursing women
  • 18.Any condition that in the judgment of the investigator would place the patient at undue risk
  • 19.History of receiving an investigational product within 30 days prior to enrollment in this study

研究者

相似试验

进行中(未招募)
不适用
Open-label, prospective, randomized, parallel group study investigating a CNI-low dose regimen with Sandimmun® Optoral and Certican® in comparison to standard immunosuppressive therapy in renal transplant patients with creeping creatinine.Maintenance outpatient renal transplant recipients at least 6 months post-transplantation, no longer than 8 years after transplantation with a creeping serum creatinine (as calculated by CAN-Slope®) and with a serum creatinine = 2.5 mg/dL stable for at least one month.MedDRA version: 12.1Level: LLTClassification code 10023438Term: Kidney transplant
EUCTR2009-012200-98-DEniversity Medical Center Hamburg-Eppendorf
进行中(未招募)
1 期
A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered subcutaneously to subfertile female patients undergoing IVF using antagonist downregulation. - PROSPECTsub fertilityMedDRA version: 7.1 Level: LLT Classification code 10042391
EUCTR2004-001307-35-GBFerring Arzneimittel GmbH72
已完成
1 期
TESTING OF HAND SANITIZER.
CTRI/2021/08/035597Guru Nanak Dev University Amritsar300
进行中(未招募)
1 期
An open 4-week study to evaluate the efficacy and safety of Serroflo ® comparing with Viani ® in patients with stable persistent asthmaAsthma
EUCTR2015-004455-52-DECipla Europe NV
尚未招募
不适用
A clinical study to Compare the Safety and Effectiveness of Digifine Capsule and Pantoprazole plus Domperidone or Pantoprazole versus Pantoprazole plus Domperidone and Pantoprazole in Patients with Functional dyspepsia
CTRI/2022/12/048631Dr Ranjana G Deshmukh